Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous metoprolol in respiratory distress due to COVID-19
2020-002310-41Phase 2Completed
- Sponsor
- Fundación Jiménez Díaz
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of metoprolol in coronavirus disease 2019 (COVID-19) and acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Fundación Jiménez Díaz. Primary endpoint: Inflammatory markers in bronchoalveolar lavage. Started Jul 2020; status: completed.
02
Drugs
metoprolol
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2020-002310-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002310-41.